EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD
REYKJAVIK, Iceland--(BUSINESS WIRE)--Aug 18, 2021-- |!| Oelwein
REYKJAVIK, Iceland--(BUSINESS WIRE)--Aug 18, 2021-- |!| Oelwein